Yu Murakami, Daisuke Kawahara, Takashi Soyano, Takuyo Kozuka, Yuka Takahashi, Konatsu Miyake, Kenichi Kashihara, Tairo Kashihara, Tatsuya Kamima, Masahiko Oguchi, et al. Dosiomics for intensity-modulated radiotherapy in patients with prostate cancer: survival analysis stratified by baseline prostate-specific antigen and Gleason grade group in a 2-institutional retrospective study. The British journal of radiology. 2024. 97. 1153. 142-149
Takero Hirata, Osamu Suzuki, Keisuke Otani, Akimitsu Miyake, Keisuke Tamari, Yuji Seo, Fumiaki Isohashi, Naoki Kai, Koji Hatano, Kazutoshi Fujita, et al. Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study. Acta oncologica (Stockholm, Sweden). 2023. 62. 5. 1-7
Kenshiro Omura, Yu Murakami, Kohei Hashimoto, Hikaru Takahashi, Ryoko Suzuki, Yasuo Yoshioka, Masahiko Oguchi, Junji Ichinose, Yosuke Matsuura, Masayuki Nakao, et al. Detection of EGFR mutations in early-stage lung adenocarcinoma by machine learning-based radiomics. Translational Cancer Research. 2023. 12. 4. 837-847
Yasuo Yoshioka, Kazuma Sasamura, Makoto Ito, Masahiro Kaneko, Taro Takahashi, Wataru Anno, Nana Shimoyachi, Junji Suzuki, Takahito Okuda, Tairo Kashihara, et al. Treatment planning comparison of high-dose-rate brachytherapy vs. robotic and conventional stereotactic body radiotherapy for ultrahypofractionated treatment of prostate cancer. Physics and Imaging in Radiation Oncology. 2023. 26. 100445-100445
Takashi Soyano, Takuyo Kozuka, Kenichi Kashihara, Yu Murakami, Junji Yonese, Kazuma Sasamura, Nana Shimoyachi, Tairo Kashihara, Yasuo Yoshioka, Masahiko Oguchi. Intensity-modulated radiation therapy for intermediate-risk prostate cancer: does ADT still have an impact in the dose-escalated external beam radiation therapy era?. Japanese Journal of Clinical Oncology. 2023. 53. 6. 514-521
